We’ve recently updated our valuation analysis.

ZimVie Valuation

Is ZIMV undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ZIMV?

Other financial metrics that can be useful for relative valuation.

ZIMV key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.8x
Enterprise Value/EBITDA20.5x
PEG Ration/a

Price to Sales Ratio vs Peers

How does ZIMV's PS Ratio compare to its peers?

The above table shows the PS ratio for ZIMV vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average3.8x
ARAY Accuray
0.5x5.0%US$229.8m
TCMD Tactile Systems Technology
1.1x11.9%US$265.4m
EAR Eargo
7x4.3%US$240.0m
KRMD KORU Medical Systems
6.5x11.8%US$176.6m
ZIMV ZimVie
0.3x-0.1%US$259.3m

Price-To-Sales vs Peers: ZIMV is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (3.8x).


Price to Earnings Ratio vs Industry

How does ZIMV's PE Ratio compare vs other companies in the US Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a17.4%
n/an/an/a

Price-To-Sales vs Industry: ZIMV is good value based on its Price-To-Sales Ratio (0.3x) compared to the US Medical Equipment industry average (3.8x)


Price to Sales Ratio vs Fair Ratio

What is ZIMV's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ZIMV PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.3x
Fair PS Ratio1.2x

Price-To-Sales vs Fair Ratio: ZIMV is good value based on its Price-To-Sales Ratio (0.3x) compared to the estimated Fair Price-To-Sales Ratio (1.2x).


Share Price vs Fair Value

What is the Fair Price of ZIMV when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ZIMV ($9.94) is trading below our estimate of fair value ($35.58)

Significantly Below Fair Value: ZIMV is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies